Jonathan Zalevsky - Chief R&D Officer, Nektar Therapeutics

As of December 20, 2021


Jonathan Zalevsky Net Worth

  • Net worth is estimated to be at least $7.01M
  • Owns at least 232,084 units of Nektar Therapeutics stock
  • Sold an estimated value of $3.06M in the last 2 years at Nektar Therapeutics

Jonathan Zalevsky Trading

  • Largest sale of shares was 31,111 units , worth over $569.33K on May 19, 2021
  • In total has made about 15 transactions over 2 years
  • Usually trades in November, with the busiest year in 2021 and 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Jonathan Zalevsky Mailing Address

  • Mailing address is 455 Mission Bay Boulevard South C/o Nektar Therapeutics San Francisco CA 94158 CA

Nektar Therapeutics Insider Trading

  • The most recent transaction was 24,149 units sold on November 18, 2021 by Gil Labrucherie worth over $316.39K
  • In the last 18 years, insiders at Nektar Therapeutics sold an estimated value of $293.47M and bought an estimated value of $84.98M
  • The most active traders are Gil Labrucherie, SVP,  Howard Robin, President & CEO,  and Robert Chess, Director
  • Insider trading is most common in September, with the busiest year in 2016 and 2017

NEKTAR THERAPEUTICS Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1